Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.7500 (-1.19%) ($20.7000 - $21.3500) on Fri. Mar. 24, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.1% (three month average) | RSI | 63 | Latest Price | $20.7500(-1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) IBB(50%) ARKG(49%) IWO(48%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -2.55% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-10%) UNG(-3%) TIP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.55% (StdDev 5.1%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
5 Day Moving Average | $20.94(-0.91%) | 10 Day Moving Average | $20.52(1.12%) | 20 Day Moving Average | $19.04(8.98%) | To recent high | -8.6% | To recent low | 64% | Market Cap | $1.542b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |